Researcher
Geert Raes
- Keywords (Vrije Universiteit Brussel):Applied biological sciences, biotechnology
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Adaptive immunology, Bacteriology
- Disciplines (Vrije Universiteit Brussel):Innate immunity, Inflammation, Nuclear imaging, Medical imaging and therapy not elsewhere classified, Applied immunology, Cancer therapy
- See also: Geert Raes (Flanders Institute for Biotechnology)
Affiliations
- Damya Laoui Lab (Research group)
Member
From1 Oct 2022 → Today - Department of Bio-engineering Sciences (Department)
Member
From8 Apr 2019 → Today - Department of Bio-engineering Sciences (Department)
Member
From8 Apr 2019 → Today - Van Ginderachter Lab (Research group)
Member
From1 Jan 2017 → Today - Department of Bio-engineering Sciences (Department)
Member
From1 Mar 2013 → Today - Department of Bio-engineering Sciences (Department)
Member
From1 Mar 2013 → Today - Cellular and Molecular Immunology (Research group)
Member
From1 Jan 2000 → Today - Department of Bio-engineering Sciences (Department)
Member
From1 Oct 1997 → Today - Cellular and Molecular Immunology (Research group)
Member
From1 Oct 1993 → Today
Projects
1 - 4 of 4
- IOF Accelerator:Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)From1 Oct 2022 → TodayFunding: IOF - technology validation in real environment
- GEAR: Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)From1 Jan 2020 → TodayFunding: IOF - technology validation in real environment, IOF - mandates
- A peripheral blood monocyte gene signature as biomarker for diagnosis of heptatocellular carcinomaFrom1 Jan 2016 → 31 Dec 2017Funding: FWO research project
- Quantitative Molecular Imaging Platform (Q-MIP)From1 Jun 2014 → 31 May 2019Funding: Hercules - Large scale research infrastructure
Publications
1 - 10 of 71
- In vivo Visualization of M2 Macrophages in the Myocardium After Myocardial Infarction (MI) Using 68 Ga-NOTA-Anti-MMR Nb(2022)
Authors: Zohreh Varasteh, Miriam Braeuer, Sarajo Mohanta, Anna-Lena Steinsiek, Andreas Habenicht, Negar Omidvari, Geoffrey J Topping, Christoph Rischpler, Wolfgang A Weber, Hendrik B. Sager, et al.
- Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions(2022)
Authors: Emma Verheye, Jesús Bravo Melgar, S Deschoemaeker, Geert Raes, Anke Maes, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Damya Laoui, Kim De Veirman
- Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha(2021)
Authors: Karen De Vlaminck, Ema Romão, Janik Puttemans, Ana Rita Pombo Antunes, Daliya Kancheva, Isabelle Scheyltjens, Jo A. Van Ginderachter, Serge Muyldermans, Nick Devoogdt, Kiavash Movahedi, et al.
- Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer(2021)
Authors: Quentin Lecocq, Pieterjan Debie, Janik Puttemans, Robin Maximilian Awad, Lien De Beck, T Ertveldt, Yannick De Vlaeminck, Cleo Goyvaerts, Geert Raes, Marleen Keyaerts, et al.
- Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade(2021)
Authors: Quentin Lecocq, Robin Maximilian Awad, Yannick De Vlaeminck, Wout de Mey, T Ertveldt, Cleo Goyvaerts, Geert Raes, Kris Thielemans, Marleen Keyaerts, Nick Devoogdt, et al.
Pages: 1638-1644 - Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade(2021)
Authors: Robin Maximilian Awad, Quentin Lecocq, Katty Zeven, T Ertveldt, Lien De Beck, Hannelore Ceuppens, Katrijn Broos, Yannick De Vlaeminck, Cleo Goyvaerts, M Verdonck, et al.
Pages: 172-182 - Lyophilization of NOTA-sdAbs(2021)
Authors: Henri Baudhuin, Pieter-Jan Van Bockstal, Thomas De Beer, Ilse Vaneycken, Jessica Bridoux, Geert Raes, V. Caveliers, Marleen Keyaerts, Nick Devoogdt, Tony Lahoutte, et al.
Pages: 194-204 - Phase I trial of 131I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients(2021)
Authors: Matthias D'Huyvetter, Jens De Vos, Vicky Caveliers, Ilse Vaneycken, Johannes Heemskerk, Francois P Duhoux, Christel Fontaine, M Vanhoeij, Albert D Windhorst, Frank Van Der Aa, et al.
Pages: 1097-1105 - Decorating sdAbs with Chelators(2021)
Authors: Henri Baudhuin, Janik Puttemans, Heleen Hanssens, Philippe Vanwolleghem, Sophie Hernot, Geert Raes, Catarina Xavier, Tony Lahoutte, Pieterjan Debie
- IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D(2021)
Authors: Máté Kiss, Lieselotte Vande Walle, Pedro H V Saavedra, Els Lebegge, Helena Van Damme, Aleksandar Murgaski, Junbin Qian, Manuel Ehling, Samantha Pretto, Evangelia Bolli, et al.
Pages: 309-323
Patents
1 - 7 of 7
- Anti-macrophage mannose receptor immunoglobulin single variable domains for targeting and in vivo imaging of tumor-associated macrophages (Inventor)
- Targeting and in vivo imaging of tumor-associated macrophages (Inventor)
- Anti-macrophage mannose receptor single variable domains for use in cardiovascular diseases (Inventor)
- Human pd-l1-binding immunoglobulins (Inventor)
- Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages (Inventor)
- Method of imaging a cardiovascular disease with an anti-macrophage mannose receptor immunoglobulin single variable domain (Inventor)
- Human pd-l1-binding immunoglobulins (Inventor)